Navigation Links
Newly Cloned Wheat Gene May Boosts Foods' Nutrient Contents – Says A Researc

Researchers have cloned a gene from wild wheat that boosts up the protein, zinc and iron content of the grain, offering solutions to //nutritional deficiencies that affect millions of children worldwide. Researchers at the University of California conducted the research along with Davis; the U.S. Department of Agriculture; and the University of Haifa in Israel and the results were published in the Nov. 24 issue of the journal Science.

"Wheat is one of the world's major crops, providing approximately one-fifth of all calories consumed by humans, therefore, even small increases in wheat's nutritional value may help decrease deficiencies in protein and key micronutrients," said Professor Jorge Dubcovsky, a wheat breeder and leader of this research group. He noted that the World Health Organization estimates that more than 2 billion people are deficient in zinc and iron, and more than 160 million children under the age of five lack an adequate protein supply.

The cloned gene, designated GPC-B1 for its effect on Grain Protein Content, accelerates grain maturity and increases grain protein and micronutrient content by 10 to 15 percent in the wheat varieties studied so far. To prove that this gene produced all these effects, the researchers created genetically modified wheat lines with reduced levels of the GPC gene by a technique called RNA interference. These lines were developed by research geneticist Ann Blechl of USDA's Agricultural Research Service in Albany, Calif.

"The results were spectacular," Dubcovsky said. "The grains from the genetically modified plants matured several weeks later than the control plants and showed 30 percent less grain protein, zinc and iron, without differences in grain size. This experiment confirmed that this single gene was responsible for all these changes."

Dubcovsky said the research team was surprised to find that all cultivated pasta and bread wheat varieties analyzed so far have a nonfunction
'"/>




Page: 1 2

Related medicine news :

1. Obesity The Major Cause Of The Increase In Newly Diagnosed Diabetes
2. Newly Identified Strains Of Chlamydia Trachomatis – A Gateway To New Disease
3. Newly Discovered Immune Defense May Be Impaired In CF Airways
4. Differences Between BP Medicines and Newly-Diagnosed Diabetes Identified
5. A Newly Identified Immunosuppressive Protein in Rheumatoid Arthritis
6. Moratorium Proposed on Advertisements of Newly Approved Drugs
7. Mad-Cow Resistant Calf Cloned in China
8. Experts on Cloned Animal Meat
9. Cloned Animal Products- To Eat Or Not To Eat ?
10. FDA Finds Animal Cloned Food to Be Safe
11. Food from Cloned Animals Will Not Have Indicative Labels
Post Your Comments:
Breaking Medicine Technology:Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5CRF announces late breaking trials to be presented at TCT 2009 in San Francisco 54339 1CRF announces late breaking trials to be presented at TCT 2009 in San Francisco 54339 2CRF announces late breaking trials to be presented at TCT 2009 in San Francisco 54339 3National Cancer Institute names Emory to nationwide NCI chemical biology consortium 54337 1National Cancer Institute names Emory to nationwide NCI chemical biology consortium 54337 2National Cancer Institute names Emory to nationwide NCI chemical biology consortium 54337 3National Cancer Institute names Emory to nationwide NCI chemical biology consortium 54337 4Accera Announces Peer Reviewed Publication of the Results of its 90 Day Clinical Study of AC 1202 28Axona 28TM 29 29 in Mild to Moderate Alzheimers 13530 1Accera Announces Peer Reviewed Publication of the Results of its 90 Day Clinical Study of AC 1202 28Axona 28TM 29 29 in Mild to Moderate Alzheimers 13530 2Accera Announces Peer Reviewed Publication of the Results of its 90 Day Clinical Study of AC 1202 28Axona 28TM 29 29 in Mild to Moderate Alzheimers 13530 3